ロード中...
The effect of sodium/glucose cotransporter 2 (SGLT2) inhibition on the urinary proteome
Treatment with empagliflozin, an inhibitor of the sodium/glucose cotransporter 2 (SGLT2), is associated with slower progression of diabetic kidney disease. In this analysis, we explored the hypothesis that empagliflozin may have an impact on urinary peptides associated with chronic kidney disease (C...
保存先:
| 出版年: | PLoS One |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5662219/ https://ncbi.nlm.nih.gov/pubmed/29084249 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0186910 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|